Short sellers have cut their CTSH position by 15.2% in a single week. The stock gained 5.7% in the same period. With earnings due July 29, options traders are leaning bullish — but analysts keep trimming targets.
Short interest fell to 11.4% of free float as of July 24, down from roughly 13.5% a week earlier. That is a drop of more than 7.7 million shares in five trading days. The covering accelerated as the stock bounced off multi-month lows.
The borrow market remains well-supplied. Availability sits at 595% — roughly six shares available for every one currently borrowed. Cost to borrow is just 0.40%, well below levels that would signal any stress in the lending pool. Shorts exiting now face no squeeze mechanics; this looks like discretionary de-risking ahead of a binary event.
Earlier this week, the put-call ratio dropped to 0.997–1.005, nearly 2.7 standard deviations below the 20-day mean of around 1.11. That is an unusual signal for a stock whose PCR typically runs above 1.1. By July 24 the PCR had drifted back to 1.14, roughly in line with the recent average, suggesting the burst of call buying was a short-term positioning move rather than a structural shift.
The pattern fits the pre-earnings playbook. Traders buying calls while shorts cover creates a one-directional flow in the days before a report.
The analyst picture is more cautious. Multiple firms slashed price targets this week after CTSH's Q2 update. JP Morgan cut its target from $74 to $55 while keeping Overweight. RBC dropped from $88 to $47 at Sector Perform. Guggenheim lowered from $80 to $65 at Buy.
The consensus mean target stands at $60.38 — a 33% premium to the current price of $45.45. That gap is wide. But every recent revision has been downward, and the string of cuts began well before earnings, suggesting analysts were already repositioning for a weaker demand environment.
The bear case centers on pricing pressure, integration risk from acquisitions, and softer discretionary IT budgets among financial services clients. The bull case rests on the Astreya acquisition, the AI Factory initiative, and strong hyperscaler relationships.
Earnings on July 29 are the immediate catalyst. The last two quarterly reports produced one-day drops of 4% and 6.4% respectively. The combination of short covering and pre-earnings call buying suggests the market is positioned for a better outcome this time — but the analyst target cuts tell a different story.
See the live data behind this article on ORTEX.
Open CTSH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
